Close

Form N-Q VANGUARD CONVERTIBLE For: Feb 29

April 28, 2016 7:14 AM EDT

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM N-Q

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF
REGISTERED MANAGEMENT COMPANY

 

Investment Company Act file number:   811-04627

 

Name of Registrant:   Vanguard Convertible Securities Fund

 

Address of Registrant:

P.O. Box 2600
Valley Forge, PA 19482

 

Name and address of agent for service:

Heidi Stam, Esquire
P.O. Box 876
Valley Forge, PA 19482

 

Date of fiscal year end:    November 30

 

Date of reporting period:   February 29, 2016

 

Item 1: Schedule of Investments

 


Vanguard Convertible Securities Fund

Schedule of Investments
As of February 29, 2016

        Face Market
    Maturity   Amount Value
  Coupon Date Currency (000) ($000)
Convertible Bonds (91.1%)          
Consumer Discretionary (10.9%)          
Cineplex Inc. Cvt. 4.500% 12/31/18 CAD 5,713 4,391
1 Ctrip.com International Ltd. Cvt. 1.000% 7/1/20 USD 20,010 20,985
1 Ctrip.com International Ltd. Cvt. 1.990% 7/1/25 USD 4,310 4,517
FF Group Finance Luxembourg Cvt. 1.750% 7/3/19 EUR 7,700 5,612
Iida Group Holdings Co. Ltd. Cvt. 0.000% 6/18/20 JPY 500,000 4,839
Jarden Corp. Cvt. 1.125% 3/15/34 USD 21,944 25,620
K's Holdings Corp. Cvt. 0.000% 12/20/19 JPY 400,000 4,119
Liberty Media Corp. Cvt. 1.375% 10/15/23 USD 21,325 20,352
LVMH Moet Hennessy Louis Vuitton SE Cvt. 0.000% 2/16/21 USD 3,594 3,758
NH Hoteles SA Cvt. 4.000% 11/8/18 EUR 6,100 7,275
NHK Spring Co. Ltd. Cvt. 0.000% 9/20/19 USD 4,050 4,146
Priceline Group Inc. Cvt. 0.350% 6/15/20 USD 19,520 23,570
Priceline Group Inc. Cvt. 0.900% 9/15/21 USD 6,165 6,227
ResortTrust Inc. Cvt. 0.000% 12/1/21 JPY 560,000 5,461
1 Restoration Hardware Holdings Inc. Cvt. 0.000% 7/15/20 USD 290 203
Sony Corp. Cvt. 0.000% 9/30/22 JPY 1,062,000 9,313
Steinhoff Finance Holdings GmbH Cvt. 1.250% 8/11/22 EUR 3,300 3,581
Sumitomo Forestry Co. Ltd. Cvt. 0.000% 8/24/18 JPY 430,000 3,894
Takashimaya Co. Ltd. Cvt. 0.000% 12/11/20 JPY 670,000 6,217
          164,080
Consumer Staples (3.3%)          
Herbalife Ltd. Cvt. 2.000% 8/15/19 USD 24,357 22,180
Marine Harvest ASA Cvt. 0.875% 5/6/19 EUR 2,200 3,255
Marine Harvest ASA Cvt. 0.125% 11/5/20 EUR 4,400 4,960
Sonae Investments BV Cvt. 1.625% 6/11/19 EUR 5,300 5,518
Vector Group Ltd. Cvt. 1.750% 4/15/20 USD 12,065 13,340
          49,253
Energy (2.5%)          
BW Group Ltd. Cvt. 1.750% 9/10/19 USD 6,400 5,384
Cheniere Energy Inc. Cvt. 4.250% 3/15/45 USD 7,380 3,792
1 Scorpio Tankers Inc. Cvt. 2.375% 7/1/19 USD 7,293 5,930
SEACOR Holdings Inc. Cvt. 2.500% 12/15/27 USD 10,410 8,725
Technip SA Cvt. 0.875% 1/25/21 EUR 5,200 6,329
TOTAL SA Cvt. 0.500% 12/2/22 USD 8,000 7,890
          38,050
Financials (14.8%)          
Aabar Investments PJSC Cvt. 1.000% 3/27/22 EUR 6,000 4,771
AmTrust Financial Services Inc. Cvt. 2.750% 12/15/44 USD 13,070 9,843
Apollo Commercial Real Estate Finance Inc.          
Cvt. 5.500% 3/15/19 USD 9,197 9,168
Aroundtown Property Holdings plc Cvt. 3.000% 5/5/20 EUR 8,300 10,700
Aroundtown Property Holdings plc Cvt. 1.500% 1/18/21 EUR 2,500 2,679
AYC Finance Ltd. Cvt. 0.500% 5/2/19 USD 2,886 2,976
Azimut Holding SPA Cvt. 2.125% 11/25/20 EUR 10,300 12,179
Beni Stabili SpA SIIQ Cvt. 0.875% 1/31/21 EUR 7,500 7,894
Blackstone Mortgage Trust Inc. Cvt. 5.250% 12/1/18 USD 6,405 6,485
British Land White 2015 Ltd. Cvt. 0.000% 6/9/20 GBP 3,400 4,472
CapitaCommercial Trust Cvt. 2.500% 9/12/17 SGD 2,250 1,686

 


 

CapitaLand Ltd. Cvt. 2.800% 6/8/25 SGD 14,750 9,898
China Overseas Finance Investment Cayman          
V Ltd. Cvt. 0.000% 1/5/23 USD 3,800 3,691
Colony Financial Inc. Cvt. 5.000% 4/15/23 USD 9,594 8,389
Colony Starwood Homes Cvt. 3.000% 7/1/19 USD 1,320 1,253
1 Element Financial Corp. Cvt. 5.125% 6/30/19 CAD 15,464 12,344
1 Element Financial Corp. Cvt. 4.250% 6/30/20 CAD 8,650 6,233
1 Empire State Realty OP LP Cvt. 2.625% 8/15/19 USD 7,925 7,935
Encore Capital Group Inc. Cvt. 3.000% 7/1/20 USD 7,668 5,622
1 Extra Space Storage LP Cvt. 3.125% 10/1/35 USD 13,235 14,393
Grand City Properties SA Cvt. 0.250% 3/2/22 EUR 3,200 3,562
Nexity SA Cvt. 0.630% 1/1/20 EUR 3,623 4,625
Portfolio Recovery Associates Inc. Cvt. 3.000% 8/1/20 USD 7,283 5,403
RWT Holdings Inc. Cvt. 5.625% 11/15/19 USD 7,800 7,020
Spirit Realty Capital Inc. Cvt. 2.875% 5/15/19 USD 11,855 11,655
Spirit Realty Capital Inc. Cvt. 3.750% 5/15/21 USD 10,830 10,688
St. Modwen Properties Securities Jersey Ltd.          
Cvt. 2.875% 3/6/19 GBP 4,800 6,436
Starwood Property Trust Inc. Cvt. 4.550% 3/1/18 USD 9,861 9,682
Starwood Property Trust Inc. Cvt. 4.000% 1/15/19 USD 13,365 12,922
Unite Jersey Issuer Ltd. Cvt. 2.500% 10/10/18 GBP 4,100 7,262
          221,866
Health Care (14.4%)          
Acorda Therapeutics Inc. Cvt. 1.750% 6/15/21 USD 10,706 10,572
Allscripts Healthcare Solutions Inc. Cvt. 1.250% 7/1/20 USD 10,095 9,937
BioMarin Pharmaceutical Inc. Cvt. 0.750% 10/15/18 USD 5,435 6,254
Brookdale Senior Living Inc. Cvt. 2.750% 6/15/18 USD 13,940 13,191
Cepheid Inc. Cvt. 1.250% 2/1/21 USD 5,205 4,395
Depomed Inc. Cvt. 2.500% 9/1/21 USD 8,315 8,388
Fresenius Medical Care AG & Co. KGaA Cvt. 1.125% 1/31/20 EUR 800 1,097
HealthSouth Corp. Cvt. 2.000% 12/1/43 USD 13,731 14,701
Healthways Inc. Cvt. 1.500% 7/1/18 USD 6,620 6,012
1 HeartWare International Inc. Cvt. 1.750% 12/15/21 USD 2,498 1,724
Hologic Inc. Cvt. 0.000% 12/15/43 USD 12,880 16,092
1 Horizon Pharma Investment Ltd. Cvt. 2.500% 3/15/22 USD 6,952 6,113
Illumina Inc. Cvt. 0.500% 6/15/21 USD 7,285 7,599
Insulet Corp. Cvt. 2.000% 6/15/19 USD 10,879 10,267
1 Ironwood Pharmaceuticals Inc. Cvt. 2.250% 6/15/22 USD 10,724 8,961
Jazz Investments I Ltd. Cvt. 1.875% 8/15/21 USD 30,006 30,118
Medicines Co. Cvt. 2.500% 1/15/22 USD 7,418 8,429
Medidata Solutions Inc. Cvt. 1.000% 8/1/18 USD 14,805 14,509
Molina Healthcare Inc. Cvt. 1.625% 8/15/44 USD 5,385 6,613
Qiagen NV Cvt. 0.375% 3/19/19 USD 3,400 3,543
Qiagen NV Cvt. 0.875% 3/19/21 USD 4,800 5,103
Terumo Corp. Cvt. 0.000% 12/6/21 JPY 810,000 8,656
Wright Medical Group Inc. Cvt. 2.000% 2/15/20 USD 15,330 13,826
          216,100
Industrials (10.1%)          
51job Inc. Cvt. 3.250% 4/15/19 USD 6,240 5,951
Aecon Group Inc. Cvt. 5.500% 12/31/18 CAD 1,852 1,383
Brenntag Finance BV Cvt. 1.875% 12/2/22 USD 9,250 9,483
Carillion Finance Jersey Ltd. Cvt. 2.500% 12/19/19 GBP 5,200 6,905
CRRC Corp. Ltd. Cvt. 0.000% 2/5/21 USD 5,250 5,381
DP World Ltd. Cvt. 1.750% 6/19/24 USD 7,400 7,123
1 Dycom Industries Inc. Cvt. 0.750% 9/15/21 USD 23,620 22,144
Echo Global Logistics Inc. Cvt. 2.500% 5/1/20 USD 7,560 7,187

 


 

GVM Debentures Lux 1 SA Cvt. 5.750% 2/14/18 EUR 6,200 5,472
Huron Consulting Group Inc. Cvt. 1.250% 10/1/19 USD 12,810 12,033
International Consolidated Airlines Group SA          
Cvt. 0.625% 11/17/22 EUR 4,900 4,909
Johnson Electric Holdings Ltd. Cvt. 1.000% 4/2/21 USD 11,000 11,385
KEYW Holding Corp. Cvt. 2.500% 7/15/19 USD 8,750 6,109
Larsen & Toubro Ltd. Cvt. 0.675% 10/22/19 USD 6,325 5,851
LIXIL Group Corp. Cvt. 0.000% 3/4/22 JPY 810,000 7,169
MISUMI Group Inc. Cvt. 0.000% 10/22/18 USD 4,600 5,480
Nagoya Railroad Co. Ltd. Cvt. 0.000% 12/11/24 JPY 750,000 7,536
Prysmian SPA Cvt. 1.250% 3/8/18 EUR 3,300 3,854
Sacyr SA Cvt. 4.000% 5/8/19 EUR 4,400 3,771
Safran SA Cvt. 0.000% 12/31/20 EUR 3,430 3,882
Shimizu Corp. Cvt. 0.000% 10/16/20 JPY 360,000 3,335
Siemens Financieringsmaatschappij NV Cvt. 1.650% 8/16/19 USD 5,250 5,530
          151,873
Information Technology (28.3%)          
Advanced Semiconductor Engineering Inc.          
Cvt. 0.000% 3/27/18 USD 6,600 5,940
Akamai Technologies Inc. Cvt. 0.000% 2/15/19 USD 540 522
ASM Pacific Technology Ltd. Cvt. 2.000% 3/28/19 HKD 18,000 2,308
1 BroadSoft Inc. Cvt. 1.000% 9/1/22 USD 9,740 10,945
Brocade Communications Systems Inc. Cvt. 1.375% 1/1/20 USD 9,085 8,835
1 CalAmp Corp. Cvt. 1.625% 5/15/20 USD 8,355 7,974
Canadian Solar Inc. Cvt. 4.250% 2/15/19 USD 6,555 5,723
Cardtronics Inc. Cvt. 1.000% 12/1/20 USD 13,885 13,113
Citrix Systems Inc. Cvt. 0.500% 4/15/19 USD 29,110 31,384
1 DH Corp. Cvt. 5.000% 9/30/20 CAD 13,003 9,852
Econocom Group Cvt. 1.500% 1/15/19 EUR 6,518 7,519
Electronics For Imaging Inc. Cvt. 0.750% 9/1/19 USD 15,280 15,414
Euronet Worldwide Inc. Cvt. 1.500% 10/1/44 USD 11,529 12,797
1 Integrated Device Technology Inc. Cvt. 0.875% 11/15/22 USD 8,760 7,879
Intel Corp. Cvt. 2.950% 12/15/35 USD 3,100 3,751
j2 Global Inc. Cvt. 3.250% 6/15/29 USD 12,676 15,449
Microchip Technology Inc. Cvt. 1.625% 2/15/25 USD 14,565 13,973
Micron Technology Inc. Cvt. 3.000% 11/15/43 USD 10,555 7,309
Nuance Communications Inc. Cvt. 1.500% 11/1/35 USD 14,438 15,178
1 Nuance Communications Inc. Cvt. 1.000% 12/15/35 USD 12,915 12,245
NXP Semiconductors NV Cvt. 1.000% 12/1/19 USD 22,731 24,038
1 ON Semiconductor Corp. Cvt. 1.000% 12/1/20 USD 7,100 6,208
Red Hat Inc. Cvt. 0.250% 10/1/19 USD 16,830 19,575
1 Rovi Corp. Cvt. 0.500% 3/1/20 USD 20,109 20,122
SanDisk Corp. Cvt. 0.500% 10/15/20 USD 39,135 40,089
Semiconductor Manufacturing International          
Corp. Cvt. 0.000% 11/7/18 USD 4,000 4,190
SunPower Corp. Cvt. 0.875% 6/1/21 USD 945 734
1 SunPower Corp. Cvt. 4.000% 1/15/23 USD 11,345 11,735
Synchronoss Technologies Inc. Cvt. 0.750% 8/15/19 USD 12,410 11,534
Trina Solar Ltd. Cvt. 3.500% 6/15/19 USD 2,975 2,824
TTM Technologies Inc. Cvt. 1.750% 12/15/20 USD 13,523 11,714
Web.com Group Inc. Cvt. 1.000% 8/15/18 USD 13,795 13,002
WebMD Health Corp. Cvt. 2.500% 1/31/18 USD 11,810 12,652
WebMD Health Corp. Cvt. 1.500% 12/1/20 USD 10,565 13,134
Yahoo! Inc. Cvt. 0.000% 12/1/18 USD 24,383 23,758
Yandex NV Cvt. 1.125% 12/15/18 USD 2,721 2,311
          425,730

 


 

Materials (4.9%)          
APERAM Cvt. 0.625% 7/8/21 USD 7,400 7,919
Buzzi Unicem SPA Cvt. 1.375% 7/17/19 EUR 3,700 4,654
Cemex SAB de CV Cvt. 3.750% 3/15/18 USD 425 391
Cemex SAB de CV Cvt. 3.720% 3/15/20 USD 19,840 15,674
Cemex SAB de CV Cvt. 3.720% 3/15/20 USD 10,515 8,307
1 Chemtrade Logistics Income Fund Cvt. 5.250% 6/30/21 CAD 5,331 3,664
NV Bekaert SA Cvt. 0.750% 6/18/18 EUR 3,600 4,066
OCI Cvt. 3.875% 9/25/18 EUR 5,200 5,737
Outokumpu OYJ Cvt. 3.250% 2/26/20 EUR 1,900 1,573
RTI International Metals Inc. Cvt. 1.625% 10/15/19 USD 14,465 14,356
Teijin Ltd. Cvt. 0.000% 12/12/18 JPY 140,000 1,366
Teijin Ltd. Cvt. 0.000% 12/10/21 JPY 610,000 6,181
          73,888
Telecommunication Services (0.5%)          
America Movil SAB de Cvt. 0.000% 5/28/20 EUR 7,600 8,185
 
Utilities (1.4%)          
Northland Power Inc. Cvt. 5.000% 6/30/19 CAD 2,661 1,996
Northland Power Inc. Cvt. 4.750% 6/30/20 CAD 6,225 4,658
1 Pattern Energy Group Inc. Cvt. 4.000% 7/15/20 USD 10,995 9,195
Suez Environnement Co. Cvt. 0.000% 2/27/20 EUR 2,336 2,882
Superior Plus Corp. Cvt. 6.000% 6/30/19 CAD 2,558 1,820
          20,551
Total Convertible Bonds (Cost $1,432,841)         1,369,576
        Shares  
Convertible Preferred Stocks (5.5%)          
Energy (0.9%)          
Kinder Morgan Inc. Pfd. 9.750%     207,900 9,381
McDermott International Inc. Pfd. 6.250%     314,400 4,002
          13,383
Financials (2.1%)          
American Tower Corp. Pfd. 5.500%     207,600 19,972
Crown Castle International Corp. Pfd. 4.500%     104,700 11,124
          31,096
Health Care (2.5%)          
Alere Inc. Pfd. 3.000%     16,405 6,345
Allergan plc Pfd. 5.500%     19,600 18,963
Teva Pharmaceutical Industries Ltd. Pfd. 7.000%     14,400 12,902
          38,210
Total Convertible Preferred Stocks (Cost $85,337)         82,689
Temporary Cash Investment (3.4%)          
Money Market Fund (3.4%)          
2 Vanguard Market Liquidity Fund (Cost          
$51,428) 0.475%     51,427,954 51,428
 
Total Investments (100.0%) (Cost $1,569,606)         1,503,693
Other Assets and Liabilities-Net (0.0%)3         (408)
Net Assets (100%)         1,503,285

1 Security exempt from registration under Rule 144A of the Securities Act of 1933. Such securities may be sold in
transactions exempt from registration, normally to qualified institutional buyers. At February 29, 2016, the
aggregate value of these securities was $211,301,000, representing 14.1% of net assets.
2 Affiliated money market fund available only to Vanguard funds and certain trusts and accounts managed by Vanguard. Rate shown is the 7-day yield.


 

3 Cash of $7,570,000 has been segregated as collateral for open forward currency contracts.
CAD—Canadian dollar.
CHF—Swiss franc.
EUR—Euro.
GBP—British pound.
HKD—Hong Kong dollar.
JPY—Japanese yen.
SEK—Swedish krona.
SGD—Singapore dollar.
USD—U.S. dollar.

A. Security Valuation: Securities are valued as of the close of trading on the New York Stock Exchange (generally 4 p.m., Eastern time) on the valuation date. Equity securities are valued at the latest quoted sales prices or official closing prices taken from the primary market in which each security trades; such securities not traded on the valuation date are valued at the mean of the latest quoted bid and asked prices. Bonds, and temporary cash investments acquired over 60 days to maturity, are valued using the latest bid prices or using valuations based on a matrix system (which considers such factors as security prices, yields, maturities, and ratings), both as furnished by independent pricing services. Investments in Vanguard Market Liquidity Fund are valued at that fund's net asset value. Other temporary cash investments are valued at amortized cost, which approximates market value. Securities for which market quotations are not readily available, or whose values have been affected by events occurring before the fund's pricing time but after the close of the securities’ primary markets, are valued at their fair values calculated according to procedures adopted by the board of trustees. These procedures include obtaining quotations from an independent pricing service, monitoring news to identify significant market- or security-specific events, and evaluating changes in the values of foreign market proxies (for example, ADRs, futures contracts, or exchange-traded funds), between the time the foreign markets close and the fund's pricing time. When fair-value pricing is employed, the prices of securities used by a fund to calculate its net asset value may differ from quoted or published prices for the same securities.

B. Foreign Currency: Securities and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars using exchange rates obtained from an independent third party as of the fund's pricing time on the valuation date. Realized gains (losses) and unrealized appreciation (depreciation) on investment securities include the effects of changes in exchange rates since the securities were purchased, combined with the effects of changes in security prices. Fluctuations in the value of other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains (losses) until the assets or liabilities are settled in cash, at which time they are recorded as realized foreign currency gains (losses).

C. Various inputs may be used to determine the value of the fund's investments. These inputs are summarized in three broad levels for financial statement purposes. The inputs or methodologies used to value securities are not necessarily an indication of the risk associated with investing in those securities.

Level 1—Quoted prices in active markets for identical securities.
Level 2—Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
Level 3—Significant unobservable inputs (including the fund's own assumptions used to determine the fair value of investments).

The following table summarizes the market value of the fund's investments as of February 29, 2016, based on the inputs used to value them:


 

Convertible Securities Fund

  Level 1 Level 2 Level 3
Investments ($000) ($000) ($000)
Convertible Bonds 1,369,576
Convertible Preferred Stocks 82,689
Temporary Cash Investments 51,428
Forward Currency Contracts—Assets 1,783
Forward Currency Contracts—Liabilities (7,596)
Total 51,428 1,446,452

 

D. Forward Currency Contracts: The fund enters into forward currency contracts to protect the value of securities and related receivables and payables against changes in future foreign exchange rates. The fund's risks in using these contracts include movement in the values of the foreign currencies relative to the U.S. dollar and the ability of the counterparties to fulfill their obligations under the contracts. The fund mitigates its counterparty risk by entering into forward currency contracts only with a diverse group of prequalified counterparties, monitoring their financial strength, entering into master netting arrangements with its counterparties, and requiring its counterparties to transfer collateral as security for their performance. The master netting arrangements provide that, in the event of a counterparty’s default (including bankruptcy), the fund may terminate the forward currency contracts, determine the net amount owed by either party in accordance with its master netting arrangements, and sell or retain any collateral held up to the net amount owed to the fund under the master netting arrangements. The forward currency contracts contain provisions whereby a counterparty may terminate open contracts if the fund's net assets decline below a certain level, triggering a payment by the fund if the fund is in a net liability position at the time of the termination. The payment amount would be reduced by any collateral the fund has pledged. Any assets pledged as collateral for open contracts are noted in the Schedule of Investments. The value of collateral received or pledged is compared daily to the value of the forward currency contracts exposure with each counterparty, and any difference, if in excess of a specified minimum transfer amount, is adjusted and settled within two business days.

Forward currency contracts are valued at their quoted daily prices obtained from an independent third party, adjusted for currency risk based on the expiration date of each contract. The notional amounts of the contracts are not recorded in the Schedule of Investments. Fluctuations in the value of the contracts are recorded as an asset (liability).

At February 29, 2016, the fund had open forward currency contracts to receive and deliver currencies as follows. Unrealized appreciation (depreciation) on open forward currency contracts, except for Hong Kong and Singapore dollar currency contracts, is treated as realized gain (loss) for tax purposes.

    Contract Amount (000)  
            Unrealized
  Contract         Appreciation
  Settlement         (Depreciation)
Counterparty Date   Receive   Deliver ($000)
UBS AG 4/21/16 CAD 2,731 USD 1,971 47
UBS AG 4/21/16 CHF 3,467 USD 3,577 (95)
UBS AG 4/21/16 EUR 16,772 USD 18,906 (631)
UBS AG 4/21/16 GBP 764 USD 1,097 (34)

 


 

Convertible Securities Fund

UBS AG 4/21/16 JPY 828,500 USD 6,914 446
UBS AG 4/21/16 JPY 84,400 USD 755 (5)
UBS AG 4/21/16 SEK 14,400 USD 1,681 5
UBS AG 4/21/16 SGD 3,890 USD 2,775 (13)
UBS AG 4/21/16 USD 44,934 CAD 65,365 (3,380)
UBS AG 4/21/16 USD 3,469 CHF 3,465 (10)
UBS AG 4/21/16 USD 153,893 EUR 140,525 774
UBS AG 4/21/16 USD 5,544 EUR 5,120 (35)
UBS AG 4/21/16 USD 27,079 GBP 19,090 504
UBS AG 4/21/16 USD 2,299 HKD 17,990 (14)
UBS AG 4/21/16 USD 73,763 JPY 8,647,205 (3,056)
UBS AG 4/21/16 USD 1,685 SEK 14,335 7
UBS AG 4/21/16 USD 13,976 SGD 20,130 (323)
            (5,813)
Refer to the Schedule of Investments for currency abbreviations.

 

E. At February 29, 2016, the cost of investment securities for tax purposes was $1,569,606,000. Net unrealized depreciation of investment securities for tax purposes was $65,913,000, consisting of unrealized gains of $39,603,000 on securities that had risen in value since their purchase and $105,516,000 in unrealized losses on securities that had fallen in value since their purchase.


Item 2: Controls and Procedures

(a) Disclosure Controls and Procedures. The Principal Executive and Financial Officers concluded that the Registrant’s Disclosure Controls and Procedures are effective based on their evaluation of the Disclosure Controls and Procedures as of a date within 90 days of the filing date of this report.

(b) Internal Control Over Financial Reporting. During the last fiscal quarter, there was no significant change in the Registrant’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Item 3: Exhibits

(a) Certifications

  VANGUARD CONVERTIBLE SECURITIES FUND
 
By: /s/ F. WILLIAM MCNABB III*
  F. WILLIAM MCNABB III
  CHIEF EXECUTIVE OFFICER
 
Date:  April 15, 2016  

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

  VANGUARD CONVERTIBLE SECURITIES FUND

 

By:
/s/ F. WILLIAM MCNABB III*
  F. WILLIAM MCNABB III
  CHIEF EXECUTIVE OFFICER

Date:  April 15, 2016

 

 

 

VANGUARD CONVERTIBLE SECURITIES FUND

 

By:

/s/ THOMAS J. HIGGINS*
  THOMAS J. HIGGINS
  CHIEF FINANCIAL OFFICER

Date:  April 15, 2016

 

 

* By:/s/ Heidi Stam
Heidi Stam, pursuant to a Power of Attorney filed on April 22, 2014 see file Number 2-17620, Incorporated by Reference.

 

 

 

CERTIFICATIONS

 

I, F. William McNabb III, certify that:

 

1. I have reviewed this report on Form N-Q of Vanguard Convertible Securities Fund;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: April 15, 2016

/s/ F. William McNabb III

 

F. William McNabb III

 

Chief Executive Officer

 

 

0362216, v0.96


 

 

CERTIFICATIONS

 

I, Thomas J. Higgins, certify that:                                                                                           

 

1. I have reviewed this report on Form N-Q of Vanguard Convertible Securities Fund;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: April 15, 2016

/s/ Thomas J Higgins

 

Thomas J. Higgins

 

Chief Financial Officer

 

0362216, v0.96



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

Vanguard